HAZEL AMIRA CALIBUGAR: Open Payments
NPI 1780264374 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 22 payments from 4 companies in 2025. Trend: 2023 $334 · 2024 $50 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $445 |
| ABIOMED | 1 | $211 |
| Edwards Lifesciences Corporation | 1 | $161 |
| PFIZER INC. | 2 | $52 |
Products named: LEQVIO, PASCAL, VYNDAQEL.
Industry payments across IL — which companies pay providers there.
